Somatic DNA damages in cardiovascular autonomic neuropathy

Area of Science:

• Cardiovascular Health
• Genetics
• Diabetes Complications

Background:

• Cardiovascular autonomic neuropathy (CAN) is a significant complication of diabetes mellitus.
• The role of somatic DNA damage in CAN pathogenesis remains under-explored.
• Existing research focuses on various etiological factors but lacks correlation with DNA damage.

Purpose of the Study:

• To assess the extent of somatic DNA damage in patients with type 2 diabetes and CAN using the cytokinesis-block micronuclei assay (CBMN).
• To investigate the correlation between lifestyle habits, risk factors, socioeconomic status, and CAN.
• To establish a potential link between DNA damage and the development of CAN.

Main Methods:

• The study employed the cytokinesis-block micronuclei assay (CBMN) to measure somatic DNA damage.
• CBMN frequency was compared between 46 type 2 diabetes patients with CAN and 25 healthy controls.
• Data on habits, risk factors (smoking, physical activity, hypertension, dyslipidemia, obesity), and socioeconomic status were collected and analyzed.

Main Results:

• Patients with CAN exhibited a statistically significant higher mean CBMN frequency compared to healthy controls (P < 0.05).
• Elevated CBMN frequency was observed in CAN patients with physical inactivity and smoking habits.
• Significant correlations were found between CAN and smoking, diabetes mellitus, hypertension, dyslipidemia, abdominal obesity, and physical activity.

Conclusions:

• Somatic DNA damage, as indicated by CBMN frequency, is significantly elevated in type 2 diabetes patients with cardiovascular autonomic neuropathy.
• Lifestyle factors, particularly smoking and physical inactivity, are associated with increased DNA damage in CAN patients.
• This study suggests that DNA damage may play a role in the pathogenesis of CAN, offering potential targets for intervention and further research.